TNBCs are often high-grade tumours (not uncommonly even devoid of obvious glandular differentiation) with poor prognosis that overlap with carcinomas classified as basal-like on the basis of gene expression profiling [1–3], especially if they express cytokeratin 5 (CK5) and/or epidermal growth factor receptor [4]. The gene discussed is KRT5; the disease is carcinoma.